The nation of Zimbabwe has declined a significant US health deal worth 367 million US dollars (£272m) over five years because of the United States' insistence on sensitive biological samples.
The decision became public following a government memo dated December was disclosed, indicating that President Emmerson Mnangagwa felt the arrangement was "lopsided".
A government representative later stated that the US was requesting biological samples for research and commercial purposes while was not willing to share the resulting advantages from future treatments.
"We must now begin the difficult and regrettable task of winding down our health assistance in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished over $1.9bn in health funding to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has called for further dialogue to secure a agreement agreeable to all parties so the nation's vital HIV programme can continue.
Broader Implications
Zimbabwe's decision comes after a comparable situation in neighbouring Kenya, where a high court halted a similar health funding agreement after concerns were raised about the security of Kenyans' medical information.
Since returning to office recently, US President Donald Trump has reduced foreign aid and shut down the key foreign aid agency.
The agency had administered assistance for the American government, but Trump argued its spending was "wasteful" and his government was pursuing direct bilateral deals to enhance openness and accountability.
Based on statements, 16 nations in Africa have to date signed similar health pacts, representing over $18.3bn in committed funds.
Details of the Declined Agreement
The money for Zimbabwe would have gone towards "tackling HIV/Aids, tuberculosis, malaria, maternal and child health, and preparing for epidemics".
"We are confident this partnership could have provided immense benefits for Zimbabwean communities, particularly the 1.2 million presently on HIV treatment via US-supported initiatives," the Ambassador commented.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"Zimbabwe was being asked to surrender its genetic material and health information over an extended period, with no equivalent promise of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"In essence, our nation would supply the raw materials for scientific discovery without any certainty that the final treatments would be available to our population should a new health crisis arise."
National Interest and International Frameworks
He also said that the US's withdrawal from the World Health Organization (WHO) and its pursuit of one-on-one deals were disrupting frameworks previously set up through the global health agency.
Mangwana cited its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This system is designed to guarantee that when a country provides its samples, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised exclusively by those with the funds to develop them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage ongoing discussions with our US partners on how subsequent collaboration could be structured in a way that honours the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) expressed it acknowledged the government's concerns, but recommended that talks should continue since much of the nation's HIV programmes relied on foreign aid.
"In cases where specific concerns arise, such as those involving data governance or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it added.
The situation highlights the ongoing challenges between receiving crucial international aid and protecting national sovereignty in an ever more interconnected world.